<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Biological psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0006-3223</issn><issn pub-type="epub">1873-2402</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5346327</article-id><article-id pub-id-type="pmcid-ver">PMC5346327.1</article-id><article-id pub-id-type="pmcaid">5346327</article-id><article-id pub-id-type="pmcaiid">5346327</article-id><article-id pub-id-type="manuscript-id">NIHMS826239</article-id><article-id pub-id-type="pmid">27939396</article-id><article-id pub-id-type="doi">10.1016/j.biopsych.2016.10.024</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS826239</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA826239</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A role for PGC1-alpha in nucleus accumbens neuron subtypes in cocaine action</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Chandra</surname><given-names initials="R">Ramesh</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Engeln</surname><given-names initials="M">Michel</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Francis</surname><given-names initials="TC">T. Chase</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Konkalmatt</surname><given-names initials="P">Prasad</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Patel</surname><given-names initials="D">Dipal</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lobo</surname><given-names initials="MK">Mary Kay</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA</aff><aff id="A2"><label>2</label>Division of Renal Diseases and Hypertension, The George Washington University, Washington, D.C, USA</aff><author-notes><corresp id="cor1"><label>*</label><bold>Correspondence should be addressed to:</bold> Mary Kay Lobo, Department of Anatomy and Neurobiology, University of Maryland, School of Medicine, 20 Penn Street, HSF2, Rm 265, Baltimore, MD 21201, <email>mklobo@som.umaryland.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P33"><bold>Financial Disclosures:</bold></p><p id="P34">All authors report no biomedical financial interests or potential conflicts of interest.</p></fn></author-notes><pub-date pub-type="epub"><day>28</day><month>10</month><year>2016</year></pub-date><pub-date pub-type="ppub"><day>01</day><month>4</month><year>2017</year></pub-date><volume>81</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">289157</issue-id><fpage>564</fpage><lpage>572</lpage><pub-history><event event-type="nihms-submitted"><date><day>29</day><month>10</month><year>2016</year></date></event><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2018</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2018</year></date></event><event event-type="pmc-released-under-embargo"><date><day>12</day><month>03</month><year>2017</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-17 13:25:17.317"><day>17</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms826239.pdf"/><abstract><sec id="S1"><title>Background</title><p id="P1">Molecules critically involved in cocaine behavioral plasticity are known to regulate and interact with peroxisome proliferator-activated receptor gamma coactivator-1alpha, PGC-1&#945;. Additionally, the PGC-1&#945; promoter has binding sites for early growth response 3 (Egr3), which plays a dynamic role in cocaine action in nucleus accumbens (NAc) medium spiny neurons (MSN) subtypes, those enriched in dopamine receptor D1 vs. D2. However, the role of PGC-1&#945; in NAc in cocaine action is unknown.</p></sec><sec id="S2"><title>Methods</title><p id="P2">PGC-1&#945; mRNA and protein were examined in NAc after repeated cocaine exposure. Binding of Egr3 to and histone methylation at the PGC-1&#945; promoter was examined in NAc, using chromatin immunoprecipitation (ChIP), after repeated cocaine. PGC-1&#945; ribosome-associated mRNA in MSN subtypes was assessed after repeated cocaine using D1-Cre-RiboTag and D2-Cre-RiboTag lines. Finally, PGC-1&#945; was expressed in NAc D1-MSNs vs. D2-MSNs using a Cre-inducible AAV and Cre lines during cocaine conditioned place preference and cocaine-induced locomotion.</p></sec><sec id="S3"><title>Results</title><p id="P3">Repeated cocaine increased PGC-1&#945; levels, and increased Egr3 binding and H3K4me3 at the PGC-1&#945; promoter in NAc. Increased PGC-1&#945; occurred in D1-MSNs, while D2-MSNs showed reduced levels. Viral mediated expression of PGC-1&#945; in D1-MSNs enhanced behavioral responses to cocaine, while expression in D2-MSNs blunted these behaviors.</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">We demonstrate a novel role for PGC-1&#945; in NAc in cocaine action. PGC-1&#945; is enhanced in NAc D1-MSNs specifically after cocaine exposure. These data are consistent with increased active methylation and Egr3 binding at the PGC-1&#945; promoter. Finally, we demonstrate a bidirectional role for PGC-1&#945; in mediating behavioral plasticity to cocaine through D1-MSNs vs. D2-MSNs.</p></sec></abstract><kwd-group><kwd>Cocaine</kwd><kwd>Nucleus accumbens</kwd><kwd>MSN subtype</kwd><kwd>RiboTag</kwd><kwd>PGC-1&#945;</kwd><kwd>Epigenetics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>